Skip to main content

Susan Kay Murphy, PhD

Property title
Associate Professor in Obstetrics and Gynecology
Campus Mail: 226 B Wing LSRC, 450 Research Drive, Durham, NC 27708
Phone: (919) 681-3423
Email: susan.murphy@duke.edu

Ovarian and cervical cancer epigenetics, imprinted genes in ovarian and cervical cancers, identification of methylation biomarkers of disease, ovarian cancer stem cells, chemotherapeutic response in ovarian cancer, tumor dormancy, the influence of the in utero environment on DNA methylation and risk of disease.

Education and Training

  • Ph.D., Wake Forest University, 1998
  • B.A., University of North Carolina at Charlotte, 1992

Selected Grants and Awards

Publications

Murphy, SK, Jayes, FL, Feng, L, Huang, Z, and Leppert, PC. "Methylation of THBS1, the Gene Encoding Thrombospondin-1 in Uterine Fibroids and Myometrium." March 2009.

Scholars@Duke

Kondoh, E, Baba, T, Malsumura, N, Konishi, I, Fujii, S, Berchuck, A, and Murphy, SK. "7-hydroxystaurosporine (UCN-01) is effective in targeting ovarian cancer spheroids." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S161-S162.

Scholars@Duke

Yamaguchi, K, Mandai, M, Matsumura, N, Baba, T, Oura, T, Matsui, S, Murphy, SK, Berchuck, A, Fujii, S, and Konishi, I. "Gene signature specific for ovarian clear cell carcinoma is induced by the contents of endometriotic cysts." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S132-S132.

Scholars@Duke

Barnett, JC, Kondoh, E, Whitaker, R, Murphy, SK, and Berchuck, A. "High poly (ADP-ribose) polymerase (PARP) expression is associated with poor survival in advanced-stage serous ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S107-S107.

Scholars@Duke

Murphy, SK, and Chen, L. "Imprinted Neuronatin: A potential epigenetie biomarker of ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S135-S135.

Scholars@Duke

Horne, HN, Lee, PS, Murphy, SK, Alonso, MA, Olson, JA, and Marks, JR. "Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy." Mol Cancer Res 7, no. 2 (February 2009): 199-209.

Full Text

Murphy, SK, Huang, Z, Wen, Y, Simel, LR, Price, TM, and Berchuck, A. "Intragenic methylation at a novel CTCF binding site is associated with elevated IGF2 expression in serous epithelial ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S138-S138.

Scholars@Duke

Baba, T, Kang, HS, Matsumura, N, Hamanishi, J, Mandai, M, Berchuck, A, Murphy, SK, and Konishi, I. "Loss of GPR54 correlates with stem cell activity in high-grade endometrial cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S78-S78.

Scholars@Duke

Resnick, KE, Alder, H, Secord, AA, Whitaker, R, Richardson, DL, Heaphy, C, Murphy, SK, Baba, T, Croce, C, and Colin, DE. "MiRNA patterns in ovarian cancer cell lines: Correlation with serum studies." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S115-S116.

Scholars@Duke

Barnett, JC, Whitaker, R, Kondoh, E, Baba, T, Murphy, SK, and Berchuck, A. "Ovarian cancer tumor-infiltrating regulatory T cells are associated with a metastatic phenotype." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S11-S11.

Scholars@Duke

Pages